Barry Canton, 10% Owner at Ginkgo Bioworks Holdings, Inc. (DNA), sold 112,950 shares at $1.63 ($173K) on 2023-12-14, disclosed to the SEC on 2023-12-15.
Scheduled sale ($173k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.34 | 36,829 | $49K | 28.5% |
| 2 | $1.48 | 821 | $1K | 0.7% |
| 3 | $1.63 | 37,650 | $61K | 35.4% |
| 4 | $1.63 | 37,650 | $61K | 35.4% |
| Total | $1.53 avg | 112,950 | $173K | 100% |
| Filing → |
| DNA | SELL | 2023-12-22 | $133K | — | Filing → |
| DNA | SELL | 2023-12-08 | $99K | — | Filing → |
| DNA | SELL | 2023-12-01 | $211K | — | Filing → |